Division of Abbott Laboratories Inc.
Latest From Axis-Shield PLC
A product derived from a bacterial protein, IdeS, could be the first medicine from Sweden's Hansa Medical to tackle a serious unmet need, transplant patients unable to find a donor match because of HLA sensitization.
Pre Diagnostics AS is a 2.5-year-old Oslo company developing a blood-based test performed by a GP and sent to a lab for early Alzheimer’s diagnosis.
Norwegian start-up CardiNor is developing a new cardiovascular biomarker, and is hopeful of attracting cash in a country where investor traditions are undergoing some changes. The financial pressures caused by falling oil prices have brought renewed attention to life science companies.
Medical device companies raised $1.1 billion, a 40% increase over Q4 2011’s $800 million. Two billion-dollar deals in the resuscitation market boosted device acquisition activity to $4.2 billion. Twenty diagnostics financings brought in a collective $302 million, soaring above the previous quarter’s $269 million. There were seven diagnostics M&A deals completed, totaling $589 million – down yet again.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Laboratory Testing Services
- Diagnostic Equipment & Supplies
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Abbott Laboratories Inc.
- Senior Management
Ian Gilham, PhD, CEO
Erling Sundrehagen, MD, PhD, CSO
George Zajicek , Bus. Dev. Dir.
Ronny Hermansen, Group Fin. Dir.
- Contact Info
Phone: (44) 1382 422000
The Technology Park
Dundee, DD2 1XA
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.